sr 95531 has been researched along with mefloquine in 1 studies
| Studies (sr 95531) | Trials (sr 95531) | Recent Studies (post-2010) (sr 95531) | Studies (mefloquine) | Trials (mefloquine) | Recent Studies (post-2010) (mefloquine) |
|---|---|---|---|---|---|
| 610 | 0 | 209 | 2,212 | 342 | 560 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Isaeva, EV; Lushnikova, IV; Lykhmus, OY; Patseva, MA; Savotchenko, AV; Skibo, GG; Skok, MV; Voytenko, LP | 1 |
1 other study(ies) available for sr 95531 and mefloquine
| Article | Year |
|---|---|
Hippocampal GABAergic interneurons coexpressing alpha7-nicotinic receptors and connexin-36 are able to improve neuronal viability under oxygen-glucose deprivation.
Topics: Aconitine; alpha7 Nicotinic Acetylcholine Receptor; Animals; Animals, Newborn; Carbenoxolone; Connexins; GABA Antagonists; gamma-Aminobutyric Acid; Gap Junction delta-2 Protein; Gene Expression Regulation; Glucose; Glutamate Decarboxylase; Hippocampus; Hypoxia; In Vitro Techniques; Interneurons; Mefloquine; Mitochondria; Nicotinic Antagonists; Organ Culture Techniques; Patch-Clamp Techniques; Pyridazines; Rats; Rats, Wistar; Synaptic Transmission | 2015 |